Epigenetic Editing in Non-Human Primates Presented by Tune at ASGCT
@tunetx_news presented their first results at #ASGCT, revealing successful #epigenetic#editing in non-human primates. Learn more: https://t.co/5LEItB0Mzc
Epigenome editing takes a major preclinical step towards a long-standing Big Dream for it:
inscribing long-term memory onto therapeutic gene targets without changing their sequence.
1. Wooo.
2. HOOOO!!!!
@MeganMolteni
https://t.co/f4SHo8OlUM
#ASGCT23 is almost here!
See our poster 12-2 PM Thur & @jkwonster's talk, Transient Delivery of Epigenome Editors Stably Represses PCSK9 & Lowers LDL Cholesterol in Non-Human Primates, Fri 9 AM.
Read the abstract: https://t.co/nVU2EtHjqj
We’re excited to announce the official launch of Tune Therapeutics and introduce our unique TEMPO platform. Our novel genetic tuning approach dials gene expression to healthy, functional levels – without breaking or rewriting DNA. Check us out here: https://t.co/jIT5VzYjjA
We're very happy to share our new study led by @jkwonster on gene editing of muscle stem cells in vivo after delivery of CRISPR with AAV vectors.
https://t.co/i7mWlEf4fL
We're very happy to share our latest work on CRISPR-based epigenome editing to program cell phenotypes, led by @jkwonster, using CRISPR-based gene activation to program human pluripotent stem cells to muscle progenitor cells. https://t.co/8QYpokeU7J